Therapeutic efficacy of intravitreal ceftazidime, imipenem, and amikacin in a swine model of posttraumatic Pseudomonas aeruginosa endophthalmitis.
Ng
E W
EW
D'Amico
D T
DT
D000583:Amikacin / Q000627:therapeutic use*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use; D004195:Disease Models, Animal; D009877:Endophthalmitis / Q000188:drug therapy* / Q000382:microbiology; D015818:Eye Infections, Bacterial / Q000188:drug therapy* / Q000209:etiology; D015807:Eye Injuries, Penetrating / Q000188:drug therapy* / Q000382:microbiology; D015378:Imipenem / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology; D013552:Swine; D014822:Vitreous Body
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D015378:Imipenem; D000583:Amikacin; D002442:Ceftazidime